FE
50
-2
FSLR
54
7
INTU
56
-4
VZ
50
3
ROST
63
12
UPS
60
9
IPG
56
3
CINF
53
2
SYK
64
-4
FITB
63
3
JWN
48
6
MLM
57
6
USB
55
-6
ROP
62
3
A
43
2
TXT
55
3
WDC
47
4
SE
61
-4
ORCL
65
-2
MRK
25
-2
FE
50
-2
FSLR
54
7
INTU
56
-4
VZ
50
3
ROST
63
12
UPS
60
9
IPG
56
3
CINF
53
2
SYK
64
-4
FITB
63
3
JWN
48
6
MLM
57
6
USB
55
-6
ROP
62
3
A
43
2
TXT
55
3
WDC
47
4
SE
61
-4
ORCL
65
-2
MRK
25
-2
Financhill
Back

Revance Therapeutics Vs. Regeneron Pharmaceuticals Industry Stock Comparison

Sell
9

RVNC
Revance Therapeutics

Last Price:
3.81
Seasonality Move:
6.97%
Sell
39

REGN
Regeneron Pharmaceuticals

Last Price:
749.70
Seasonality Move:
14.6%
Sell
9
Revance Therapeutics (RVNC) is a Sell

Is Revance Therapeutics a Buy, Sell or Hold?

  • The current Revance Therapeutics [RVNC] share price is $3.73. The Score for RVNC is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
  • RVNC is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
39
Regeneron Pharmaceuticals (REGN) is a Sell

Is Regeneron Pharmaceuticals a Buy, Sell or Hold?

  • The current Regeneron Pharmaceuticals [REGN] share price is $738.00. The Score for REGN is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • REGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RVNC Stock Price Chart

What is Revance Therapeutics's stock price today?

  • The Revance Therapeutics share price today is $3.73
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RVNC is experiencing selling pressure, which indicates risk of future bearish movement.

REGN Stock Price Chart

What is Regeneron Pharmaceuticals's stock price today?

  • The Regeneron Pharmaceuticals share price today is $738.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing selling pressure, which indicates risk of future bearish movement.

RVNC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.45 Sell
Relative Strength Index (14 RSI): 32.99 Sell
Chaikin Money Flow: -1111191 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.97 - 5.77) Sell
Bollinger Bands (100): (3.78 - 6.28) Sell

REGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -60.82 Sell
Relative Strength Index (14 RSI): 13.13 Sell
Chaikin Money Flow: -973600 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (767.55 - 916.07) Sell
Bollinger Bands (100): (904.84 - 1161.96) Sell

RVNC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.98 Sell
20-day SMA: 4.79 Sell
50-day SMA: 5.16 Sell
200-day SMA: 4.6 Sell
8-day EMA: 3.99 Sell
20-day EMA: 4.48 Sell
50-day EMA: 4.92 Sell
200-day EMA: 6.01 Sell

REGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 759.51 Sell
20-day SMA: 815.56 Sell
50-day SMA: 948.17 Sell
200-day SMA: 1001.38 Sell
8-day EMA: 761.76 Sell
20-day EMA: 815.61 Sell
50-day EMA: 913.33 Sell
200-day EMA: 973.48 Sell

Revance Therapeutics Earnings Growth & RVNC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.51 per share, and an increase next year of $0.58 per share.

Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.42 per share, and an increase next year of $0.41 per share.

Revance Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Regeneron Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):